Loading
CREB1 (Cyclic AMP-responsive element-binding protein 1) is a protein that switches other genes on and off. The public catalogues list it as a fusion partner, and the evidence so far is association rather than a proven role. Tied to Breast cancer, Sarcomas, Skin cancer and 1 more.
Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-119 phosphorylation. Involved in different cellular processes including the synchronisation of circadian rhythmicity and the differentiation of adipose cells.
Open Targets scores its association with cancer at 0.63 (direct and indirect evidence; datatypes literature 0.99, animal model 0.57, genetic association 0.00, somatic mutation 0.97).
In plain words · CREB1 (Cyclic AMP-responsive element-binding protein 1) is a protein that switches other genes on and off. The public catalogues list it as a fusion partner, and the evidence so far is association rather than a proven role. Tied to Breast cancer, Sarcomas, Skin cancer and 1 more.
CREB1 (Cyclic AMP-responsive element-binding protein 1) is a protein that switches other genes on and off. The public catalogues list it as a fusion partner, and the evidence so far is association rather than a proven role. Tied to Breast cancer, Sarcomas, Skin cancer and 1 more.
Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters.
No product in this corpus aims at CREB1 yet. Transcription factors have no pocket to plug, so drugs either degrade them or block the partner protein they need to dock on DNA.
First described 1988. Earliest sequence paper UniProt cites for the protein: Hoeffler J.P. et al, Science, 1988, "Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA". Source.
Sources: HGNC HGNC:2345 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt P16220 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000118260 (association with cancer (MONDO_0004992) 0.63; per-cancer scores at or above 0.5: melanoma 0.52, sarcoma 0.52, skin cancer 0.51, breast cancer 0.52 (GraphQL API, CC0))
Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-119 phosphorylation. Involved in different cellular processes including the synchronisation of circadian rhythmicity and the differentiation of adipose cells. Regulates the expression of apoptotic and inflammatory response factors in cardiomyocytes in response to ERFE-mediated activation of AKT signalling. Location: Nucleus (UniProt). Locus 2q33.3 (HGNC).
Query for this target: (TITLE:"CREB1" OR ABSTRACT:"CREB1" OR TITLE:"cAMP responsive element binding protein 1" OR ABSTRACT:"cAMP responsive element binding protein 1" OR TITLE:"Cyclic AMP-responsive element-binding protein 1" OR ABSTRACT:"Cyclic AMP-responsive element-binding protein 1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CREB1, not a curated reading list.